



Oral peptides, without the needle
Most peptides must be injected: acid and enzymes break them down in the stomach, and under 1% is absorbed when swallowed. Our printed pill-in-pill carries KPV or BPC-157 past the stomach and releases it in the colon. Since October 2026, HHS lets 503A pharmacies compound six peptides; only KPV and BPC-157 are covered for oral use.

Colon-targeted KPV and BPC-157
Our patent-pending CORR3CT™ pill-in-pill holds through the stomach and releases the peptide in the colon, where gut disease is. Prescribed through PERSONALIZ3D™ telehealth and printed for each patient at PD Labs, our U.S. 503A Center of Excellence.
Compounded products are patient-specific prescriptions and are not FDA-approved. No efficacy claims are made. Pill-in-pill image is a render.
3D-printed medicines platform
Precise, room-temperature (no heat, no UV) printing of customized doses on GMP-ready CraftMake™ systems.
CraftMake™ pharmaceutical 3D printer

Dosage forms
Pill-in-pill tablets
Gummies & chewables
Pellets & mini-tablets
Multi-layered tablets
Liquid-embedded chewables
Liquid-core chewables
Multi-layered capsules
Oral dissolvable filmsRelease profiles
Ways to work with us
Bring 3D printing in-house
For 503A pharmacies, hospitals, CDMOs and labs. A CraftMake™ printer with software, training and service included.
CraftMake™ placements →Let us make it
Our services include product development, white-label, clinical trial supply and small-batch commercial production.
View services →
